Evaluation of the skin melanoma screening program in the Krasnoyarsk territory in 2017 and 2023: observational retrospective study
- 作者: Palkina N.V.1, Ruksha T.G.1
-
隶属关系:
- Voino-Yasenetsky Krasnoyarsk State Medical University
- 期: 卷 29, 编号 1 (2024)
- 页面: 33-42
- 栏目: Original Study Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/268320
- DOI: https://doi.org/10.17816/onco631750
- ID: 268320
如何引用文章
详细
BACKGROUND: “Melanoma Diagnosis Day” is an annual campaign conducted in many regions in order to draw attention to the problem of melanoma and other skin cancers, as well as early detection of skin neoplasms (SN). Despite the fact that there is no convincing effectiveness evidence of melanoma screening, the goal of the campaign is to inform the public about the primary and secondary prevention of skin cancer.
AIM: To evaluate and compare the results of the event “Melanoma Diagnosis Day” in the Krasnoyarsk Territory in 2017 and 2023.
MATERIALS AND METHODS: An observational retrospective study was conducted, including the analysis of completed questionnaires and patient examination data in order to identify risk factors for the development of skin melanoma and other skin diseases. Statistical processing of the results was carried out on the basis of constructing conjugacy tables, followed by determining the level of statistical significance using the exact Fisher criterion.
RESULTS: In the “Melanoma Diagnosis Day” in the Krasnoyarsk Territory took a part about 234 people aged 1 to 85 years in 2017, and 207 people aged 3 to 84 years in 2023. In 2017, 1.3% of patients had suspected melanoma of the skin, 7.7% had dysplastic nevi and 0.9% had basal cell carcinoma. In 2023, clinical signs of melanoma were detected in 2.4% of patients, dysplastic nevi in 3.9% of patients, basal cell carcinoma in 1% of patients and squamous cell carcinoma in 0.5% of participants. Other types of skin neoplasms had 29.5% of participants in 2017 and 34.3% in 2023. Patients with clinical signs of melanoma and other skin diseases were referred for further examination to a regional oncological dispensary. According to the results of comparing the results of the 2017 and 2023 campaigns, it was found that in 2023 the share of nonresident participants decreased, as well as the number of participants aged 50 to 64 years. The participants’ oncological alertness, their awareness of risk factors and methods of prevention of skin fever increased.
CONCLUSION: Taking into account not only the diagnostic, but also the educational component, the “Melanoma Diagnosis Day” is an event aimed at attracting the attention of the population regarding SN.
作者简介
Nadezhda Palkina
Voino-Yasenetsky Krasnoyarsk State Medical University
Email: Mosmannv@yandex.ru
ORCID iD: 0000-0002-6801-3452
SPIN 代码: 7534-4443
MD, Dr. Sci. (Medicine)
俄罗斯联邦, 1 Partizan Zheleznyak street, 660022 KrasnoyarskTatiana Ruksha
Voino-Yasenetsky Krasnoyarsk State Medical University
编辑信件的主要联系方式.
Email: tatyana_ruksha@mail.ru
ORCID iD: 0000-0001-8142-4283
SPIN 代码: 5412-2148
MD, Dr. Sci. (Medicine), Professor
俄罗斯联邦, 1 Partizan Zheleznyak street, 660022 Krasnoyarsk参考
- Kaprin AD, Starinskii VV, Shakhzadova AO, editors. Malignant neoplasms in Russia in 2021 (morbidity and mortality). Moscow: National Medical Research Radiological Centre; 2022. (In Russ).
- Eremina EN, Karakhanian AR, Vakhrunin DA, et al. Molecular genetic markers of pigmentary melanoma (review). Siberian Medical Review. 2020;(3):38−46. doi: 10.20333/2500136-2020-3-38-46
- Saginala K, Barsouk A, Aluru JS, et al. Epidemiology of melanoma. Med Sci (Basel). 2021;9(4):63. doi: 10.3390/medsci9040063
- Djavid AR, Stonesifer C, Fullerton BT, et al. Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence. Cancers (Basel). 2021;13(19):4914. doi: 10.3390/cancers13194914
- Stratigos AJ, Forsea AM, van der Leest RJ, et al. Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future. Br J Dermatol. 2012;167(2):99−104. doi: 10.1111/j.1365-2133.2012.11092.x
- Demidov LV, Sinelnikov IE, Baryshnikov KA. et al. Perspectives for skin melanoma screening in Russia. Journal of N.N. Blokhin Russian Cancer Research Center RAMS. 2017;28(1–2):28−35. EDN: XNDIFV
- Del Marmol V. Prevention and screening of melanoma in Europe: 20 years of the Euromelanoma campaign. J Eur Acad Dermatol Venereol. 2022;36(6):5−11. doi: 10.1111/jdv.18195
- Forsea AM. Melanoma epidemiology and early detection in europe: diversity and disparities. Dermatol Pract Concept. 2020;10(3):e2020033. doi: 10.5826/dpc.1003a33
- Lieberherr S, Seyed Jafari SM, Cazzaniga S, et al. Evaluation of the National Skin Cancer Campaign: a Swiss experience of Euromelanoma. Swiss Med Wkly. 2017;147:w14511. doi: 10.4414/smw.2017.14511
- Palkina N, Sergeeva O, Ruksha T, et al. Melanoma Screening Day in Krasnoyarsk Krai of the Russian Federation: Results from 2015-2016. Asian Pac J Cancer Prev. 2018;19(2):503−507. doi: 10.22034/APJCP.2018.19.2.503
- Stojanović L, Bajić Ž. The heterogeneity of population with high risk for melanoma and other skin cancer: a latent class analysis. Eur J Cancer Prev. 2022;31(2):190−197. doi: 10.1097/CEJ.0000000000000679
- Karlsson O, Hagberg O, Nielsen K, et al. Difference in sun exposure habits between individuals with high and low risk of skin cancer. Dermatol Pract Concept. 2021;11(4):e2021090. doi: 10.5826/dpc.1104a90
- Demidov L, Samoylenko I, Vand N, et al. Screening for melanoma and other skin cancer shows a higher early melanoma incidence: Social Educational Program «Life Fear-Free». Dermatopathology (Basel). 2021;8(1):54−68. doi: 10.3390/dermatopathology8010011
- Welch HG, Mazer BL, Adamson AS. The rapid rise in cutaneous melanoma diagnoses. N Engl J Med. 2021;384(1):72–79. doi: 10.1056/NEJMsb2019760
补充文件
